In context of the emerging multidisciplinary research about AHR signaling, further understanding of the mechanisms underlying may provide a novel therapeutic target for obesity and its related metabolic disorders. This evidence concerns the gene AHR and obesity due to melanocortin 4 receptor deficiency.